-
Our Vision is to improve healthcare as a global provider of innovative and reliable diagnostic tests. -
Our Mission is to identify and develop novel patentable diagnostic markers and technologies which can be commercialised to meet clinical needs, both in the laboratory and at the point of care. -
We will collaborate with partners, create branded products and identify complementary businesses which support our objective of continuing to grow as a respected and profitable healthcare company. -
Our Values include meeting all current and future regulatory, quality and environmental standards appropriate for our industry and the countries in which we operate.
We are continuing our programme aimed at the identification and acquisition of novel markers, and the delivery of new patented tests to our partners, capitalising on our proven new marker development and commercialisation capabilities.
In 2009 we signed a global agreement with Hansa Medical, of Lund, Sweden, for exclusive rights to a diagnostic assay for heparin binding protein (HBP) as a promising marker for severe sepsis and related conditions. Under the terms of the agreement, Axis-Shield will develop tests for HBP and seek commercial partners to incorporate the assay onto the menus of high-throughput laboratory systems.
Sepsis is an acute systemic response to infection, often with fever, tachycardia, hypotension, increased respiratory rate and abnormal white cell counts. The mortality rate of severe sepsis estimated at 28-50%, six times higher than from acute myocardial infarction, with annual costs in Europe alone of €7.6 billion. Our new HBP assay will be available for testing in 2012 and data to date suggest the test is more promising for identification of severe sepsis than tests for existing markers.
For more information please visit www.heparinbindingprotein.com
Axis-Shield at a Glance
A pioneering organisation focused on the development and manufacturing of important and innovative in vitro diagnostic tests for use in clinical laboratories and at the point of care.
Focus on Afinion
Axis-Shield's award winning point-of-care test system is designed for maximum simplicity coupled with laboratory accuracy and reliability for a number of key markers important for improved patient management.
